Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
KNSA 10.22.2024
LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) --Kiniksa Pharmaceuticals International, plc(Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 29, 2024 at 8:30 a.m. Eastern Time to report its third quarter 2024 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website atwww.kiniksa.com. Individuals interested in participating in the call via telephone may registerhere. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About KiniksaKiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visitwww.kiniksa.com.
ARCALYST®is a registered trademark of Regeneron Pharmaceuticals, Inc.
Every Second Counts!®
Kiniksa Investor ContactJonathan Kirshenbaum(781) 829-3949jkirshenbaum@kiniksa.com
Kiniksa Media ContactTyler Gagnon(781) 431-9100tgagnon@kiniksa.com
